Microbot Medical (MBOT)
(Delayed Data from NSDQ)
$0.88 USD
0.00 (-0.23%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $0.88 0.00 (-0.11%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum C VGM
Income Statements
Fiscal Year end for Microbot Medical Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 13 | 11 | 9 | 7 |
Income After Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Non-Operating Income | -1 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -11 | -13 | -11 | -9 | -7 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -11 | -13 | -11 | -9 | -7 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -11 | -13 | -11 | -9 | -7 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -10 | -13 | -11 | -9 | -7 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.20 | 7.26 | 7.11 | 7.12 | 4.27 |
Diluted EPS Before Non-Recurring Items | -1.05 | -1.81 | -1.59 | -1.29 | -1.70 |
Diluted Net EPS (GAAP) | -1.05 | -1.81 | -1.59 | -1.29 | -1.70 |
Fiscal Year end for Microbot Medical Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 2.51 | 2.39 | 2.07 | 2.54 | 2.33 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.51 | -2.39 | -2.07 | -2.54 | -2.33 |
Non-Operating Income | 0.05 | 0.01 | -1.09 | 0.10 | 0.04 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.47 | -2.37 | -3.15 | -2.45 | -2.29 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.47 | -2.37 | -3.15 | -2.45 | -2.29 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.47 | -2.37 | -3.15 | -2.45 | -2.29 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 14.85 | 14.06 | 10.20 | 11.71 | 9.20 |
Diluted EPS Before Non-Recurring Items | -0.17 | -0.17 | -0.26 | -0.21 | -0.25 |
Diluted Net EPS (GAAP) | -0.17 | -0.17 | -0.23 | -0.21 | -0.25 |